Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M18.3Revenue $M0.5Net Margin (%)-8,037.8Altman Z-Score-8.4
Enterprise Value $M-22.1EPS $-27.7Operating Margin %-7,697.8Piotroski F-Score4
P/E(ttm)--Beneish M-Score24.5Pre-tax Margin (%)-8,061.3Higher ROA y-yN
Price/Book0.510-y EBITDA Growth Rate %--Quick Ratio2.1Cash flow > EarningsY
Price/Sales7.65-y EBITDA Growth Rate %-24.7Current Ratio2.1Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-69.6Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-293.2Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M6.3ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with AEZS

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AEZSFirst Eagle Investment 2010-03-31 Sold Out $474 - $558.06
($499.44)
$ 2.90-99%Sold Out0
AEZSFirst Eagle Investment 2009-12-31 Reduce$473.4 - $750
($609.06)
$ 2.90-100%Reduce -91.09%208
AEZSFirst Eagle Investment 2009-09-30 Buy 0.02%$534 - $1698
($965.96)
$ 2.90-100%New holding2,330
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AEZS is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


AEZS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Ernst, JrgenDirector 2014-11-12Buy0$2.82064903134E+41-100view
Ernst, JrgenDirector 2014-11-12Buy0$2.90479839411E+41-100view
Ernst, JrgenDirector 2014-11-12Buy0$2.89069514895E+41-100view
Ernst, JrgenDirector 2014-11-12Buy0$2.88646417541E+41-100view
Ernst, JrgenDirector 2014-11-12Buy0$2.88928482444E+41-100view
Dodd, David AlanDirector, Senior Officer 2014-11-10Buy0$2.65611117118E+41-100view
Dodd, David AlanDirector, Senior Officer 2014-11-10Buy0$2.67820625526E+41-100view
Dodd, David AlanDirector, Senior Officer 2014-11-10Buy0$2.67961657978E+41-100view
Dodd, David AlanDirector, Senior Officer 2014-11-10Buy0$2.70312198837E+41-100view
Dodd, David AlanDirector, Senior Officer 2014-11-10Buy0$2.72662739696E+41-100view

Quarterly/Annual Reports about AEZS:

    News about AEZS:

    Articles On GuruFocus.com
    Billionaires Hold Waning Biotechs 42% Off Oct 16 2013 
    Can Keryx Succeed Without Partnership? Apr 24 2012 
    Keryx Still Has High Potential from Zerenex Apr 12 2012 
    Opportunistic Coat-tailing Jan 05 2010 

    More From Other Websites
    Aeterna Zentaris to Participate in 18th Annual BIO CEO & Investor Conference Seeking Partnering... Feb 01 2016
    January 29, 2016 Aeterna Zentaris Announces Appointments to Board of Directors Jan 29 2016
    Aeterna Zentaris Announces Appointments to Board of Directors Jan 29 2016
    January 26, 2016 Aeterna Zentaris Files International Patent Application for Novel Method of... Jan 26 2016
    Aeterna Zentaris Files International Patent Application for Novel Method of Manufacturing Zoptrex™ Jan 26 2016
    January 25, 2016 Aeterna Zentaris Announces Additional Market Purchases of Common Shares by... Jan 25 2016
    AEterna Zentraris Surged 17%: Here Is What You Need To Know Jan 25 2016
    Aeterna Zentaris Announces Additional Market Purchases of Common Shares by Executive Management Jan 25 2016
    Why Are These Stocks Seeing Green Today? Jan 19 2016
    4 Small Cap NASDAQ/NYSE Stocks That Are Trading with Heavy Volume Today Jan 19 2016
    January 19, 2016 Aeterna Zentaris Concludes Successful Meeting of Clinical Investigators for... Jan 19 2016
    Aeterna Zentaris Concludes Successful Meeting of Clinical Investigators for Confirmatory Phase 3... Jan 19 2016
    January 13, 2016 Aeterna Zentaris affirms focus on targeted oncology during 34th Annual J.P. Morgan... Jan 13 2016
    Aeterna Zentaris Affirms Focus on Targeted Oncology During 2016 J.P. Morgan Healthcare Conference Jan 13 2016
    December 30, 2015 Aeterna Zentaris Announces Filing of Preliminary Base Shelf Prospectus Jan 11 2016
    Aeterna Zentaris Announces Filing of Preliminary Base Shelf Prospectus Dec 30 2015
    Equities Lead Investor Sentiment -- Free Research on AEterna Zentaris, AMAG Pharmaceuticals,... Dec 22 2015
    December 14, 2015 Aeterna Zentaris Announces Closing of US$16.65 Million Public Offering of Common... Dec 15 2015
    Aeterna Zentaris Announces Closing of US$16.65 Million Public Offering of Common Shares and Warrants Dec 14 2015
    5 Companies That Absolutely Destroyed Shareholders This Past Week Dec 12 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK